Industry criticizes government’s cancellation plan of selected innovative drug firms

The complaint over the government’s impetuous plan to remove the “innovative drug firm” status has flared among the domestic drug industry.

The Ministry of Health and Welfare in June last year had selected some 40 plus pharmaceutical companies, including Dong-A Pharmaceutical, to spearhead growth and transparency in the sector.

Many have expressed “deep regret” about the ministry’s hasty ...